Alphatec Holdings Inc

For the period ended Oct 29, 2024. Filed Oct 30, 2024.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Oct 29, 2024 · Filed Oct 30, 2024

Use the contents to explore the available documents and sections.

ATEC$7.44-4.6%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

EX-99.1 · Increased Existing Term Debt Facility

Increased Existing Term Debt Facility

The Company reached an agreement with Braidwell LP, and Pharmakon Advisors, LP, to expand the Company’s existing term loan by $50 million, availing total capacity of up to $200 million. With the close of the transaction, the Company has pro-forma cash of approximately $128 million.

Pedro Gonzalez de Cosio, Co-Founder, Principal and CEO of Pharmakon Advisors, said, “ATEC’s mission to improve spine care is fueling exceptional growth. We are excited to partner with the team in support of that important mission as the company continues to expand profitability and inflects to positive cash flow.”

Additional details regarding the financing will be included in a Current Report on Form 8-K, which ATEC will file with the Securities and Exchange Commission today.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.